Mesasal
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
♦ Mezavant 1.2g is a higher-strength, delayed and extended-release tablet formulation of mesalamine, a drug also known as 5…
Ulcerative colitis (UC) mucosa is associated with a cytokine imbalance with predominance of Th2 cytokines vs. Th1. A probiotic…
Since the beginning of the 1940s salazosulfapyridine (SASP) has been used in the treatment of chronic inflammatory bowel disease…
Investigators: This multicentre study was conducted by 29 principal investigators in 11 countries.
The pharmacokinetic profile of a new 4-g 5-aminosalicyclic acid (5-ASA) retention enema, Mesasal, was investigated. Nine patients…
A randomized, double‐blind, placebo‐controlled multicentre study was undertaken to evaluate the safety and efficacy of coated…
An Eudragit‐L coated oral 5‐aminosalicylic acid (5‐ASA; mesalazine) product (Mesasal), has been formulated to deliver 5‐ASA to…